IFN-ε Is Constitutively Expressed by Cells of the Reproductive Tract and Is Inefficiently Secreted by Fibroblasts and Cell Lines

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Hermant, Pascale ^a   Francius, Cédric ^a   Clotman, Frédéric ^a   Michiels, Thomas ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON A; BETA INTERFERON; EPSILON INTERFERON; INTERFERON; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOPLASMIC RETICULUM; FEMALE; FEMALE GENITAL SYSTEM; FIBROBLAST; GENE; HUMAN; HUMAN CELL; IFNE GENE; IN VIVO STUDY; MALE; MALE GENITAL SYSTEM; MOUSE; NONHUMAN; OASL2 GENE; OVARY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; UPREGULATION; UTERUS; VIRUS INFECTION;

EID: 84881263776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071320     Document Type: Article

References (28)

1. Isaacs A, Lindenmann J, (1957) Virus interference. I. Interferon Proc R Soc Lond B Biol Sci 147: 258-267. doi:10.1098/rspb.1957.0048.
2. Uzé G, Schreiber G, Piehler J, Pellegrini S, (2007) The receptor of the type I interferon family. Curr Top Microbiol Immunol 316: 71-95. doi:10.1007/978-3-540-71329-6_5. PubMed: 17969444.
3. Liu SY, Sanchez DJ, Cheng G, (2011) New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23: 57-64. doi:10.1016/j.coi.2010.11.003. PubMed: 21123041.
4. Randall RE, Goodbourn S, (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47. doi:10.1099/vir.0.83391-0. PubMed: 18089727.
5. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485. doi:10.1038/nature09907. PubMed: 21478870.
6. Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ, (2004) Characterization of the type I interferon locus and identification of novel genes. Genomics 84: 331-345. doi:10.1016/j.ygeno.2004.03.003. PubMed: 15233997.
7. van Pesch V, Lanaya H, Renauld JC, Michiels T, (2004) Characterization of the murine alpha interferon gene family. J Virol 78: 8219-8228. doi:10.1128/JVI.78.15.8219-8228.2004. PubMed: 15254193.
8. Manry J, Laval G, Patin E, Fornarino S, Itan Y, et al. (2011) Evolutionary genetic dissection of human interferons. J Exp Med 208: 2747-2759. doi:10.1084/jem.20111680. PubMed: 22162829.
9. Sang Y, Rowland RR, Hesse RA, Blecha F, (2010) Differential expression and activity of the porcine type I interferon family. Physiol Genomics 42: 248-258. doi:10.1152/physiolgenomics.00198.2009. PubMed: 20406849.
10. Fung KY, Mangan NE, Cumming H, Horvat JC, Mayall JR, et al. (2013) Interferon-epsilon protects the female reproductive tract from viral and bacterial infection. Science 339: 1088-1092. doi:10.1126/science.1233321. PubMed: 23449591.
11. Huang J, Smirnov SV, Lewis-Antes A, Balan M, Li W, et al. (2007) Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A 104: 9822-9827. doi:10.1073/pnas.0610352104. PubMed: 17517620.
12. Day SL, Ramshaw IA, Ramsay AJ, Ranasinghe C, (2008) Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy. J Immunol 180: 7158-7166. PubMed: 18490714.
13. Peng FW, Duan ZJ, Zheng LS, Xie ZP, Gao HC, et al. (2007) Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes. Protein Expr Purif 53: 356-362. doi:10.1016/j.pep.2006.12.013. PubMed: 17287131.
14. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387. PubMed: 3031469.
15. Aaronson SA, Todaro GJ, (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol 72: 141-148. doi:10.1002/jcp.1040720208. PubMed: 4301006.
16. van Pesch V, Michiels T, (2003) Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem 278: 46321-46328. doi:10.1074/jbc.M302554200. PubMed: 12930842.
17. Michiels T, Dejong V, Rodrigus R, Shaw-Jackson C, (1997) Protein 2A is not required for Theiler's virus replication. J Virol 71: 9549-9556. PubMed: 9371618.
18. Duke GM, Osorio JE, Palmenberg AC, (1990) Attenuation of Mengo virus through genetic engineering of the 5' noncoding poly(C) tract. Nature 343: 474-476. doi:10.1038/343474a0. PubMed: 2153940.
19. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L, (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25: 217-222. doi:10.1038/76095. PubMed: 10835641.
20. Shaw-Jackson C, Michiels T, (1999) Absence of internal ribosome entry site-mediated tissue specificity in the translation of a bicistronic transgene. J Virol 73: 2729-2738. PubMed: 10074119.
21. Roderick HL, Campbell AK, Llewellyn DH, (1997) Nuclear localisation of calreticulin in vivo is enhanced by its interaction with glucocorticoid receptors. FEBS Lett 405: 181-185. doi:10.1016/S0014-5793(97)00183-X. PubMed: 9089287.
22. Paul S, Michiels T, (2006) Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J Gen Virol 87: 1237-1246. doi:10.1099/vir.0.81642-0. PubMed: 16603526.
23. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, et al. (2006) Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 103: 7835-7840. doi:10.1073/pnas.0602460103. PubMed: 16682623.
24. Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, et al. (2012) Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 37: 171-186. doi:10.1016/j.immuni.2012.05.020. PubMed: 22749822.
25. Sommereyns C, Michiels T, (2006) N-glycosylation of murine IFN-beta in a putative receptor-binding region. J Interferon Cytokine Res 26: 406-413. doi:10.1089/jir.2006.26.406. PubMed: 16734561.
26. Petersen TN, Brunak S, von Heijne G, Nielsen H, (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8: 785-786. doi:10.1038/nmeth.1701. PubMed: 21959131.
27. Kawamoto S, Oritani K, Asada H, Takahashi I, Ishikawa J, et al. (2003) Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1. J Virol 77: 9622-9631. doi:10.1128/JVI.77.17.9622-9631.2003. PubMed: 12915574.
28. Oritani K, Kincade PW, Zhang C, Tomiyama Y, Matsuzawa Y, (2001) Type I interferons and limitin: a comparison of structures, receptors, and functions. Cytokine Growth Factor Rev 12: 337-348. doi:10.1016/S1359-6101(01)00009-0. PubMed: 11544103.